Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,202 INR | +0.92% | -2.14% | +7.14% |
05-02 | Ami Organics Board to Consider Final Dividend for Fiscal 2024 | MT |
04-26 | Ami Organics Limited announced that it expects to receive INR 990.99932 million in funding | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 75.87 times its estimated earnings per share for the ongoing year.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.14% | 527M | B | ||
+1.22% | 78.18B | B | ||
+1.46% | 47.18B | A- | ||
+0.96% | 32.47B | C | ||
+8.77% | 18.01B | B | ||
-8.58% | 11.74B | B | ||
+8.55% | 11.47B | A- | ||
-2.44% | 10.43B | - | ||
+5.97% | 9.98B | A- | ||
+4.50% | 9.12B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AMIORG Stock
- Ratings Ami Organics Limited